CGRP and CGRP-Receptor as Targets of Migraine Therapy Brain Prize-2021 /
Migraine is a highly prevalent primary headache with an unclear pathomechanism. During the last 40 years numerous hypotheses have arisen, among them the theory of the trigeminovascular system is the primary one. It serves as a skeleton in successful preclinical studies and in the development of effe...
Saved in:
Main Authors: |
Tajti János Szok Délia Nyári Aliz Vécsei László |
---|---|
Format: | Article |
Published: |
2022
|
Series: | CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
21 No. 6 |
Subjects: | |
doi: | 10.2174/1871527320666211011110307 |
mtmt: | 32365599 |
Online Access: | http://publicatio.bibl.u-szeged.hu/23805 |
Similar Items
-
CGRP antagonists and antibodies for the treatment of migraine
by: Vécsei László, et al.
Published: (2015) -
From CGRP to PACAP, VIP, and Beyond Unraveling the Next Chapters in Migraine Treatment /
by: Tanaka Masaru, et al.
Published: (2023) -
Effects of the peptides endothelin and CGRP on cerebral blood vessels in vitro
by: Szok Délia
Published: (2004) -
Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors
by: Tajti János, et al.
Published: (2014) -
CGRP outflow into jugular blood and cerebrospinal fluid and permeance for CGRP of rat dura mater
by: Risch Miriam, et al.
Published: (2021)